Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 2Other hematologic neoplasm 1Lymphoid 1Breast 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 110Leukemia 58Lymphoma 41Burkitt Lymphoma 35Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 25Lymphoma, Large B-Cell, Diffuse 19Lymphoma, Non-Hodgkin 18Leukemia, Lymphocytic, Chronic, B-Cell 17Recurrence 13Lymphoma, Large-Cell, Anaplastic 11Lymphoma, Follicular 11Lymphoma, Mantle-Cell 10Lymphoma, Large-Cell, Immunoblastic 10Lymphoma, B-Cell, Marginal Zone 10Leukemia, Biphenotypic, Acute 10Multiple Myeloma 8Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 7Blast Crisis 7Myelodysplastic Syndromes 6Leukemia, Myeloid, Acute 6Immunoblastic Lymphadenopathy 6Hodgkin Disease 6Hematologic Neoplasms 5Myeloproliferative Disorders 4Lymphoma, T-Cell, Peripheral 4Lymphoma, T-Cell, Cutaneous 4Leukemia, Myeloid, Accelerated Phase 4Dendritic Cell Sarcoma, Interdigitating 4Waldenstrom Macroglobulinemia 3Sezary Syndrome 3

Interventions

Aprepitant 7Ondansetron 6Palonosetron 3Granisetron 3Dexamethasone 3dexamethasone 21-phosphate 2Cyclophosphamide 2Calcium Dobesilate 2ramosetron 1dexamethasone acetate 1Tropisetron 1Sugars 1Olanzapine 1Immunoenzyme Techniques 1Drug Therapy 1Doxorubicin 1Control Groups 1Cisplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Vomiting × Doxorubicin × Other hematologic neoplasm × Clear all
NCT02116530 2025-01-28

Antiemetic Therapy With or Without Olanzapine in Preventing Chemotherapy-Induced Nausea and Vomiting in Patients With Cancer Receiving Highly Emetogenic Chemotherapy

Alliance for Clinical Trials in Oncology

Phase 3 Completed
401 enrolled 14 charts
Other hematologic neoplasm

Nausea, Vomiting, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡